Ozurdex (Dexamethasone)

Dexamethasone, the active ingredient in Ozurdex, is a corticosteroid presented as a biodegradable implant for intravitreal use. It treats macular edema associated with retinal vein occlusion, non‑infectious uveitis and diabetic diabetes.

GNH USA supplies Ozurdex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Ozurdex is a corticosteroid implant that addresses inflammatory and vascular‑related eye conditions.

- Macular edema secondary : Reduces the risk of vision loss in patients with RVO and diabetic macular edema. - Non‑non‑non non non :   -  . - . - . - .